Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Telehealth use plummets after pandemic highs

Use of the telehealth soared in 2020, but utilization has since fallen off a cliff after changing conditions of the COVID-19 pandemic. 

Brainomix stroke CT imaging

Explainable stroke AI cleared for US sales

The FDA has OK’d a new artificial intelligence platform for quickly diagnosing stroke on unenhanced CT scans.

Hospital finance

More financial challenges ahead for not-for-profit hospitals

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

25% of parents lied about their child’s health or vaccine status during pandemic

According to a new study published in JAMA Network Open, these lies directly contributed to COVID-19 morbidity and mortality. 

Thumbnail

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Atrium Health and Best Buy Health Partner to Improve Experience When Receiving Care at Home

Best Buy makes healthcare play with Atrium Health partnership

The new collaboration aims to enable providers to provide hospital-level care at home, leaning on Atrium Health’s telemedicine services and Best Buy Health’s ongoing care at home platform.

Sahil Parikh explains the tread of cardiology departments treating critical limb ischemia (CLI) at AHA 2022.

Interventional cardiology's role in treating CLI continues to evolve

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

Heart failure specialist Sean Pinney named new chief of cardiology at Mount Sinai Morningside

The move represents a return of sorts for Pinney, who served Mount Sinai in a variety of leadership roles from 2004 to 2020.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.